Why is Ipca Labs falling/rising?

As of 10-Jul, Ipca Laboratories Ltd's stock price is currently at 1,451.00, reflecting a decrease of 6.5 points or 0.45%. The stock has been experiencing a downward trend, having lost 1.02% over the last two days. Despite this recent decline, the stock has shown a positive performance over the past month, with a return of 5.98%. Additionally, it has generated an impressive return of 18.36% over the past year, significantly outperforming the broader market's return of 4.09%. However, the stock's delivery volume has decreased by 36.07% compared to the 5-day average, indicating a drop in investor participation, which may contribute to the recent price decline.
In the broader market context, the stock's short-term performance has been relatively strong compared to the benchmark, as it has gained 2.49% over the past week while the Sensex has remained nearly flat at -0.06%. Despite the recent price drop, the company has demonstrated solid fundamentals, including a low debt-to-equity ratio and consistent positive results over the last four quarters, with a significant growth in profit after tax. The high institutional holdings at 46.82% suggest that informed investors are backing the stock, which could provide some stability. However, the stock's performance year-to-date remains negative at -14.22%, contrasting with the Sensex's gain of 6.46%, indicating that while there are positive factors, the overall market sentiment may still be affecting the stock's price negatively.